Skip to main content
Top
Published in: European Journal of Nutrition 2/2019

01-03-2019 | Original Contribution

Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil

Authors: Roberto Carnevale, Daniele Pastori, Cristina Nocella, Vittoria Cammisotto, Simona Bartimoccia, Marta Novo, Maria Del Ben, Alessio Farcomeni, Francesco Angelico, Francesco Violi

Published in: European Journal of Nutrition | Issue 2/2019

Login to get access

Abstract

Purpose

Post-prandial phase is characterized by enhanced oxidative stress but the underlying mechanism is unclear. We investigated if gut-derived lipopolysaccharide (LPS) is implicated in this phenomenon and the effect of extra virgin olive oil (EVOO) in patients with impaired fasting glucose (IFG).

Methods

This is a randomized cross-over interventional study including 30 IFG patients, to receive a lunch with or without 10 g of EVOO. Serum LPS, Apo-B48, markers of oxidative stress such as oxidized LDL (oxLDL) and soluble Nox2-derived peptide (sNox2-dp), a marker of nicotinamide-adenine-dinucleotide-phosphate oxidase isoform Nox2 activation, and plasma polyphenols were determined before, 60 and 120 min after lunch.

Results

In patients not given EVOO oxidative stress as assessed by sNox2-dp and oxLDL significantly increased at 60 and 120 min concomitantly with an increase of LPS and Apo-B48. In these patients, changes of LPS were correlated with Apo-B48 (Rs = 0.542, p = 0.002) and oxLDL (Rs = 0.463, p = 0.010). At 120 min, LPS (β − 15.73, p < 0.001), Apo-B48 (β − 0.14, p = 0.004), sNox2-dp (β − 5.47, p = 0.030), and oxLDL (β − 42.80, p < 0.001) significantly differed between the two treatment groups. An inverse correlation was detected between polyphenols and oxLDL (R − 0.474, p < 0.005). In vitro study showed that LPS, at the same concentrations found in the human circulation, up-regulated Nox2-derived oxidative stress via interaction with Toll-like receptor 4.

Conclusions

Post-prandial phase is characterized by an oxidative stress-related inflammation potentially triggered by LPS, a phenomenon mitigated by EVOO administration.
Literature
1.
go back to reference Valdivielso P, Puerta S, Rioja J et al (2010) Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls. Clin Chim Acta 411(5–6):433–437CrossRefPubMed Valdivielso P, Puerta S, Rioja J et al (2010) Postprandial apolipoprotein B48 is associated with asymptomatic peripheral arterial disease: a study in patients with type 2 diabetes and controls. Clin Chim Acta 411(5–6):433–437CrossRefPubMed
2.
go back to reference O’Keefe JH, Bell DSH (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100(5):899–904CrossRefPubMed O’Keefe JH, Bell DSH (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100(5):899–904CrossRefPubMed
3.
go back to reference Meigs JB, Nathan DM, D’Agostino RB Sr et al (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care 25(10):1845–1850CrossRefPubMed Meigs JB, Nathan DM, D’Agostino RB Sr et al (2002) Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham offspring study. Diabetes Care 25(10):1845–1850CrossRefPubMed
4.
go back to reference ECODE Study Group (2001) The European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161(3):397–405CrossRef ECODE Study Group (2001) The European Diabetes Epidemiology Group Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161(3):397–405CrossRef
5.
go back to reference Carnevale R, Bartimoccia S, Nocella C, Di Santo S et al (2014) LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis 237(1):108–116CrossRefPubMed Carnevale R, Bartimoccia S, Nocella C, Di Santo S et al (2014) LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis 237(1):108–116CrossRefPubMed
6.
go back to reference Harte AL, Varma MC, Tripathi G et al (2012) High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35(2):375–382CrossRefPubMedPubMedCentral Harte AL, Varma MC, Tripathi G et al (2012) High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care 35(2):375–382CrossRefPubMedPubMedCentral
7.
go back to reference Nocella C, Carnevale R, Bartimoccia S et al (2017) Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost 117(8):1558–1570CrossRefPubMed Nocella C, Carnevale R, Bartimoccia S et al (2017) Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost 117(8):1558–1570CrossRefPubMed
8.
go back to reference Carnevale R, Pignatelli P, Nocella C et al (2014) Extra virgin olive oil blunt post-prandial oxidative stress via NOX2 down-regulation. Atherosclerosis 235(2):649–658CrossRefPubMed Carnevale R, Pignatelli P, Nocella C et al (2014) Extra virgin olive oil blunt post-prandial oxidative stress via NOX2 down-regulation. Atherosclerosis 235(2):649–658CrossRefPubMed
9.
go back to reference Nóvoa FJ, Boronat M, Saavedra P et al (2005) Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde study. Diabetes Care 28(10):2388–2393CrossRefPubMed Nóvoa FJ, Boronat M, Saavedra P et al (2005) Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde study. Diabetes Care 28(10):2388–2393CrossRefPubMed
10.
go back to reference Carnevale R, Pastori D, Nocella C et al (2017) Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose. Nutr Metab Cardiovasc Dis 27(10):890–895CrossRefPubMed Carnevale R, Pastori D, Nocella C et al (2017) Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose. Nutr Metab Cardiovasc Dis 27(10):890–895CrossRefPubMed
11.
go back to reference American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28:S37–S42 American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28:S37–S42
12.
go back to reference Serafini M, Maiani G, Ferro-Luzzi A (1998) Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr 128(6):1003–1007CrossRefPubMed Serafini M, Maiani G, Ferro-Luzzi A (1998) Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr 128(6):1003–1007CrossRefPubMed
13.
go back to reference Pignatelli P, Carnevale R, Cangemi R et al (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367CrossRefPubMed Pignatelli P, Carnevale R, Cangemi R et al (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30:360–367CrossRefPubMed
14.
go back to reference Carnevale R, Pignatelli P, Lenti L et al (2007) LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 21(3):927–934CrossRefPubMed Carnevale R, Pignatelli P, Lenti L et al (2007) LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 21(3):927–934CrossRefPubMed
15.
go back to reference Wiedermann CJ, Kiechl S, Dunzendorfer S et al (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34(7):1975–1981CrossRefPubMed Wiedermann CJ, Kiechl S, Dunzendorfer S et al (1999) Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. J Am Coll Cardiol 34(7):1975–1981CrossRefPubMed
16.
go back to reference Ghoshal S, Witta J, Zhong J et al (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50(1):90–97CrossRefPubMed Ghoshal S, Witta J, Zhong J et al (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50(1):90–97CrossRefPubMed
17.
go back to reference Clemente-Postigo M, Queipo-Ortuño MI, Murri M et al (2012) Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res 53(5):973–978CrossRefPubMedPubMedCentral Clemente-Postigo M, Queipo-Ortuño MI, Murri M et al (2012) Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients. J Lipid Res 53(5):973–978CrossRefPubMedPubMedCentral
18.
go back to reference Van Greevenbroek MM, De Bruin TW (1998) Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 141:S9–S16 Van Greevenbroek MM, De Bruin TW (1998) Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis 141:S9–S16
19.
go back to reference Violi F, Loffredo L, Pignatelli P et al (2015) Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects. Nutr Diabetes 5:e172CrossRefPubMedPubMedCentral Violi F, Loffredo L, Pignatelli P et al (2015) Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects. Nutr Diabetes 5:e172CrossRefPubMedPubMedCentral
20.
go back to reference Perez-Herrera A, Delgado-Lista J, Torres-Sanchez LA et al (2012) The postprandial inflammatory response after ingestion of heated oils in obese persons is reduced by the presence of phenol compounds. Mol Nutr Food Res 56(3):510–514CrossRefPubMed Perez-Herrera A, Delgado-Lista J, Torres-Sanchez LA et al (2012) The postprandial inflammatory response after ingestion of heated oils in obese persons is reduced by the presence of phenol compounds. Mol Nutr Food Res 56(3):510–514CrossRefPubMed
21.
go back to reference Xiao C, Dash S, Morgantini C et al (2014) Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans. Diabetes 63(7):2394–2401CrossRefPubMedPubMedCentral Xiao C, Dash S, Morgantini C et al (2014) Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans. Diabetes 63(7):2394–2401CrossRefPubMedPubMedCentral
22.
Metadata
Title
Gut-derived lipopolysaccharides increase post-prandial oxidative stress via Nox2 activation in patients with impaired fasting glucose tolerance: effect of extra-virgin olive oil
Authors
Roberto Carnevale
Daniele Pastori
Cristina Nocella
Vittoria Cammisotto
Simona Bartimoccia
Marta Novo
Maria Del Ben
Alessio Farcomeni
Francesco Angelico
Francesco Violi
Publication date
01-03-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 2/2019
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-018-1718-x

Other articles of this Issue 2/2019

European Journal of Nutrition 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine